Ophthalmology

Doç. Dr. Mehmet Orkun Sevik

Doctor and researcher Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi İstanbul
Macular EdemaDiabetic RetinopathyRetinitis PigmentosaMyopiaCataractStrabismus
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Macular Edema 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Diabetic Retinopathy 6 publications
  • Retinitis Pigmentosa 3 publications
  • Myopia 2 publications
  • Cataract 2 publications
  • Strabismus 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyOphthalmologysaglik.gov.trFrom source
  • InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workMacular EdemaExtracted from 7 publications · Model version —From source
  • Publications57 publicationsOpenAlex, Europe PMC, ORCIDFrom source
  • ORCID0000-0001-7130-4798ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1395204/doktorlarimiz.html#mehmet-orkun-seviksaglik.gov.tr

Scientific work

Publications on Macular Edema

57 publications

  1. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261480211 PMID 42630057 Open-access full textSource: OpenAlex

  2. Ocular and Psychosocial Outcomes After Pediatric Open Globe Injury Repair

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9188151/v1 Open-access full textSource: OpenAlex

  3. Comparison of Optical Coherence Tomography Biomarkers in Nonproliferative and Proliferative Diabetic Retinopathy: Marmasia Study Group Report No. 2

    Turkish journal of ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.24196 PMID 42928578 Open-access full textSource: Europe PMC

  4. Intravitreal nintedanib attenuates proliferative vitreoretinopathy in a mouse model: Efficacy, safety, and mechanistic insights

    Experimental Eye Research, 2026

    DOI 10.1016/j.exer.2026.111115 PMID 42264059 Source: OpenAlex

  5. Association between central serous chorioretinopathy and personality types: A systematic review and meta-analysis

    Acta ophthalmologica, 2026

    DOI 10.1111/aos.70097 PMID 41670338 Open-access full textSource: Europe PMC

  6. Association between central serous chorioretinopathy and personality types: A systematic review and meta-analysis.

    Open Access CRIS of the University of Bern, 2026

    DOI 10.48620/94697 Open-access full textSource: OpenAlex

  7. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

    Eye, 2025

    DOI 10.1038/s41433-025-03928-6 PMID 40664760 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  8. Real-Life Comparison of Off-Label Intravitreal Biosimilar Bevacizumab-awwb and Reference Bevacizumab in Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2025

    DOI 10.31067/acusaglik.1528212 1 citation (OpenAlex) Open-access full textSource: ORCID

  9. Impact of the Valsalva manoeuvre on the choroid: A systematic review with meta‐analyses

    Acta Ophthalmologica, 2025

    DOI 10.1111/aos.16793 PMID 39503538 2 citations (Europe PMC) Open-access full textSource: ORCID

  10. Decoding the Genetic Puzzle of Inherited Retinal Dystrophies: Novel Insights From a Turkish Cohort

    Clinical Genetics, 2025

    DOI 10.1111/cge.14769 PMID 40371729 1 citation (Europe PMC) Open-access full textSource: ORCID

View all 57 publications